|Bid||0.0000 x 900|
|Ask||0.0000 x 2200|
|Day's Range||1.0100 - 1.1200|
|52 Week Range||0.6000 - 2.5300|
|Beta (5Y Monthly)||2.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 18, 2012|
|1y Target Est||5.60|
Subscribe to Yahoo Finance Plus to view Fair Value for SPPI
HENDERSON, Nev., July 29, 2022--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2022 financial results and provide a corporate update on Thursday, August 11, 2022 at 8:30 a.m. Eastern/5:30 a.m. Pacific.
Moderna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine, targeting the Nipah virus. It also starts a mid-stage study evaluating its Zika virus vaccine.
JAZZ, GKOS and SPPI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 13, 2022.